Article and Video CATEGORIES

Cancer Journey

Search By

Search here for cancer terms and phrases within cancerGRACE.org, and find tons of great information available on the GRACE website.

Clinical Trials of Immune Checkpoint Inhibitors as First Line Therapy for Advanced NSCLC
gracevideo
Author
GRACE Videos and Articles

LCAM 2015

 

Dr. Jack West summarizes the rationale for testing immune checkpoint inhibitors as a first line treatment for patients with advanced NSCLC and highlights details of two trials testing this question.

November is Lung Cancer Awareness Month. What are you grateful for?

Watch, read, and then share your own stories of empowerment in our online forum. Your story may inspire others.

[powerpress]

Get more information about the IMpower-110 Trial and CheckMate-227 Trial.

[ratingwidget post_id=0]

Check out more LCAM videos & posts here.

Tags
advanced non-small cell lung cancer
atezolizumab
CheckMate-227
clinical trial
Current Clinical Trials
Dr. Jack West
first line therapy
Immunotherapy
IMpower-110 trial
ipilumumab
Lung Cancer
nivolumab
NSCLC
Opdivo
SCI
Swedish Cancer Institute
Yervoy

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation

Next Previous link

Previous PostNext Post

Related Content

Ovarian Cancer 2024
2024 Ovarian Cancer Patient Education Program
Video
In these videos, Dr.
Lung Cancer OncTalk 2024
Lung Cancer OncTalk 2024
Video
The 2024 Lung Cancer OncTalk was a live, virtual, interactive patient education event presented in December 2024, moderated by Dr. Ibiayi Dagogo-Jack, Assistant Professor of Medicine at Harvard Medical School and a Medical Oncologist at Massachusetts General Hospital, and joined by speakers: Dr. Misty Shields, Indiana University School of Medicine, Dr. Alissa Cooper, Memorial Sloan Kettering Cancer Center, Dr. Angel Qin, University of Michigan Rogel Cancer Center, and Dr. Julia Rotow, Harvard Medical School.  Topics include:
Blood Cancers OncTalk 2024
Blood Cancers OncTalk 2024
Video
  This event was moderated by Dr. Sridevi Rajeeve, Memorial Sloan Kettering, joined by speakers: Dr. Hamza Hashmi, Memorial Sloan Kettering, Dr. Michele Stanchina, University of Miami, Dr. Muhammad Salman Faisal, Oklahoma University, and Dr. Andrew Srisuwananukorn, Ohio State University Topics include: - Myeloma 101: Facts and Fiction of the 'Myeloma Marathon' - Updates in DLBCL - Treatment Basics of Bone Marrow Transplant - Frontline Therapies in Myelofibrosis - Panel Discussions and a Question-and-Answer session

Forum Discussions

Lung Cancer OncTalk 2024 On Demand
Lung Cancer OncTalk this Saturday Dec 14, 2024
Thank You to our Sponsors Lilly Oncology, Janssen and Merck
Thank You to Our Sponsor Daiichi-Sankyo
Three Year Post Update

Hi Stan,

It's so good to hear you and yours are doing well and that you were able to spend time with both families for Thanksgiving.  I know it meant a...

Three Year Post Update

Hi Stan!  It is good to hear from you -- I am so very happy you are doing well.  I agree with Janine that family and friends - our chosen family...

If You Have Lung Cancer Please Help Build Better Resourses

Recent Comments

JOIN THE CONVERSATION
Progression on Tagrisso (Osimertinib)
The chemo my father received…
By zhengchenji18 on
Progression on Tagrisso (Osimertinib)
updates:
My father received…
By zhengchenji18 on
Ischial body
Thank you so much for the…
By SavannahRae on
A question regarding treating plan of SCLC
Check out Small Cell…
By JanineT GRACE … on